Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 2, 2011, Pages 229-237

  Niedoszytko, M ^a,b   Oude Elberink, J N G ^b   Bruinenberg, M ^b   Nedoszytko, B ^a   De Monchy, J G R ^b   Te Meerman, G J ^b   Weersma, R K ^b   Mulder, A B ^b   Jassem, E ^a   Van Doormaal, J J ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

gene expression; gene profiling; mastocytosis

Indexed keywords

JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; RNA; STAT PROTEIN; UBIQUITIN;

ADULT; AGED; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME ANALYSIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYSTEMIC MASTOCYTOSIS; TRANSCRIPTION REGULATION;

EID: 78651060064     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02477.x     Document Type: Article

References (35)

1. Valent P, Sperr W, Schwartz L, Horny H,. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. J Allergy Clin Immunol 2004; 114: 3-11.
2. Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A, et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006; 108: 2366-2372.
3. Nedoszytko B, Niedoszytko M, Lange M, van Doormaal J, GleÅ J, ZabÅotna M, et al. Interleukin-13 promoter gene polymorphism -1112C/T is associated with the systemic form of mastocytosis. Allergy 2009; 64: 287-294.
4. Daley T, Metcalfe D, Akin C,. Association of the Q576R polymorphism in the interleukin-4 receptor alpha chain with indolent mastocytosis limited to the skin. Blood 2001; 98: 880-882.
5. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560-10564.
6. Lawley W, Hird H, Mallinder P, McKenna S, Hargadon B, Murray A, et al. Detection of an activating c-kit mutation by real-time PCR in patients with anaphylaxis. Mutat Res 2005; 572: 1-13.
7. Kazmierska J, Malicki J,. Application of the Naîve Bayesian Classifier to optimize treatment decisions. Radiother Oncol 2008; 86: 211-216.
8. Nogales-Cadenas R, Carmona-Saez P, Vazquez M, Vicente C, Yang X, Tirado F, et al. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res 2009; 124: 514-521.
9. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008; 36: 480-484.
10. Fehrmann RS, de Jonge HJ, Ter Elst A, de Vries A, Crijns AG, Weidenaar AC, et al. A new perspective on transcriptional system regulation (TSR): towards TSR profiling. PLoS ONE 2008; 3: e1656.
11. Liu SM, Xavier R, Good KL, Chtanova T, Newton R, Sisavanh M, et al. Immune cell transcriptome datasets reveal novel leukocyte subset-specific genes and genes associated with allergic processes. J Allergy Clin Immunol 2006; 118: 496-503.
12. D'ambrosio C, Akin C, Wu Y, Magnusson MK, Metcalfe DD,. Gene expression analysis in mastocytosis reveals a highly consistent profile with candidate molecular markers. J Allergy Clin Immunol 2003; 112: 1162-1170.
13. Varmeh-Ziaie S, Ichimura K, Yang F, Rabbits P, Collins VP,. Cloning and chromosomal localization of human WIG-1/PAG608 and demonstration of amplification with increased expression in primary squamous cell carcinoma of the lung. Cancer Lett 2001; 174: 179-187.
14. Semba S, Iwaya K, Matsubayashi J, Serizawa H, Kataba H, Hirano T, et al. Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung. Clin Cancer Res 2006; 12: 2449-2454.
15. Wang JC, Cruchaga C, Saccone NL, Bertelsen S, Liu P, Budde JP, et al. Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum Mol Genet 2009; 18: 3125-3135.
16. Johnstone CN, Castellví-Bel S, Chang LM, Sung RK, Bowser MJ, Piqué JM, et al. PRR5 encodes a conserved proline-rich protein predominant in kidney: analysis of genomic organization, expression, and mutation status in breast and colorectal carcinomas. Genomics 2005; 85: 338-351.
17. Puiffe ML, Le Page C, Filali-Mouhim A, Zietarska M, Ouellet V, Tonin PN, et al. Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia 2007; 9: 820-829.
18. Pillozzi S, Brizzi MF, Bernabei PA, Bartolozzi B, Caporale R, Basile V, et al. VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood 2007; 110: 1238-1250.
19. Grosjean-Raillard J, Tailler M, AdÃs L, Perfettini JL, Fabre C, Braun T, et al. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene 2009; 28: 1099-1109.
20. Matsuo Y, Drexler HG, Harashima A, Okochi A, Shimizu N, Orita K,. Transcription factor expression in cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma. Hum Cell 2004; 17: 85-92.
21. Bursen A, Moritz S, Gaussmann A, Moritz S, Dingermann T, Marschalek R,. Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology? Oncogene 2004; 23: 6237-6249.
22. Pinyol M, Bea S, Plà L, Ribrag V, Bosq J, Rosenwald A, et al. Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis. Blood 2007; 109: 5422-5429.
23. Soler G, Nusbaum S, Varet B, Macintyre EA, Vekemans M, Romana SP, et al. LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome. Leukemia 2009; 23: 1359-1361.
24. Li Y, Li W, Yang Y, Lu Y, He C, Hu G, et al. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res 2009; 1286: 13-18.
25. Cheong JK, Gunaratnam L, Zang ZJ, Yang CM, Sun X, Nasr SL, et al. TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors. J Transl Med 2009; 7: 8.
26. Goishi K, Mizuno K, Nakanishi H, Sasaki T,. Involvement of Rab27 in antigen-induced histamine release from rat basophilic leukemia 2H3 cells. Biochem Biophys Res Commun 2004; 324: 294-301.
27. Kuroda TS, Fukuda M,. Rab27A-binding protein Slp2-a is required for peripheral melanosome distribution and elongated cell shape in melanocytes. Nat Cell Biol 2004; 6: 1195-1203.
28. Ruault M, Brun ME, Ventura M, RoizÃs G, De Sario A,. MLL3, a new human member of the TRX/MLL gene family, maps to 7q36, a chromosome region frequently deleted in myeloid leukaemia. Gene 2002; 284: 73-81.
29. Lee JS, Yang EJ, Kim IS,. The roles of MCP-1 and protein kinase Cdelta activation in human eosinophilic leukemia EoL-1 cells. Cytokine 2009; 48: 186-195.
30. Lu JG, Sun YN, Wang C, Jin de J, Liu M,. Role of the alpha v-integrin subunit in cell proliferation, apoptosis and tumor metastasis of laryngeal and hypopharyngeal squamous cell carcinomas: a clinical and in vitro investigation. Eur Arch Otorhinolaryngol 2009; 266: 89-96.
31. Zwerger M, Herrmann H, Gaines P, Olins AL, Olins DE,. Granulocytic nuclear differentiation of lamin B receptor-deficient mouse EPRO cells. Exp Hematol 2008; 36: 977-987.
32. Johnson KR, Johnson KY, Becker KP, Bielawski J, Mao C, Obeid LM,. Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra-and extracellular sphingosine-1-phosphate levels and cell viability. J Biol Chem 2003; 278: 34541-34547.
33. Valencia CA, Ju W, Liu R,. Matrin 3 is a Ca2+/calmodulin-binding protein cleaved by caspases. Biochem Biophys Res Commun 2007; 361: 281-286.
34. Crijns AP, Fehrmann RS, de Jong S, Gerbens F, Meersma GJ, Klip HG, et al. Survival-related profile, pathways, and transcription factors in ovarian cancer. PLoS Med 2009; 6: e24.
35. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536.